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The systemic administration of tetracycline
is associated with a fall in skin surface free
fatty acids (ifa) (1). Topical tetracycline re-
duces the formation of ifa from exogenous tri-
glycerides applied to the skin (2). This study
reports the effect of topical tetracycline on ifa
production from endogenous skin surface lipids.
MATERIALS AND METHODS
Seventeen adult men on the dermatology serv-
ice of the Cleveland VA Hospital were studied.
Potential subjects were excluded for the follow-
ing reasons: (1) dermatitis of the surface lipid
collection site, (2) dermatologic problem requir-
ing topical treatment of the face, scalp, or neck,(3) systemic medications known to alter cutaneous
or blood lipids, (4) abnormal liver function tests
or (5) history of alcoholism. All subjects studied
received the same hospital diet. The environment
was air conditioned during the summer months.
Ivory® soap was used for washing and hygiene
preparations containing antibacterial compounds
were specifically eliminated.
The subjects were divided into three groups.
Nine men composed the study group and each
day they applied approximately 0.5 to 1.0 ml of
2% tetracycline hydrochloride in N,N-dimethyl-
acetamide (DMA) to the forehead, cheeks, and
chin. A fresh solution of tretracycline was prepared
each week. One control group consisted of three
men who applied plain DMA to the facial areas
once daily. The remaining five subjects applied
nothing. The three groups were studied concur-
rently.
Two measures of skin surface lipids were fol-
lowed: skin surface total lipid production and
skin surface ifa production. Baseline values for
each parameter were the mean of two collections
done on consecutive days. Follow-up determina-
tions were then done throughout the study at
weekly or bi-weekly intervals depending on pa-
tient availability. If more than one collection was
done during a given week, the mean of the values
was taken as the value for that period. Occasionally
a sample was lost due to a laboratory accident.
Skin surface free fatty acids were measured in all
subjects. Total surface lipid was followed in fifteen
subjects. Inability to obtain a tight seal of the eel—
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lection cylinder against the skin prevented collec-
tions in the other two subjects.
Skin surface total lipid production rates were
determined as follows: a 36.4 cm2 area on the
cheek was washed three times with 20 ml of
reagent grade acetone introduced into a glass
cylinder held against the skin. Three hours later
the central 27.4 cm2 of the larger area was washed
three times with 15 ml of reagent grade acetone.
These latter washings were passed through lipid-
free filter paper, evaporated into micro weighing
bottles, desiccated over CaC12 and olive oil and
then weighed to constant weight. The ability of
the acetone washings to remove surface lipids was
shown when the lipid removed by three additional
acetone washings of the 27.4 criY was consistently
1cs than 2% ef that removed by th first three
washings. For skin surface ifa collections, a 14.5
cm2 area on the forehead was washed three times
with spectroquality grade acetone introduced into
a glass cylinder. Three hours later, the central
6.2 cm2 was washed twice with 3 ml of an acidified
heptane-isopropyl alcohol mixture. The combined
washings were extracted with water and the
residual acids in the heptane layer were measured
by a non-aqueous titration system using tetra-
butylammonium hydroxide as the titrant. This
procedure measured surface total ifa and did not
differentiate which particular ffa were present. In
a test of the ability of the heptane-isopropanol
to remove surface ifa, 93.5% of oleate-1-C14 pre-
viously applied to the skin was found in the
heptane-isopropanol washings.
Preliminary studies showed tetracycline hydro-
chloride added directly to the titration mixture
interfered with the ffa determinations. The tetra-
cycline hydrochloride was titrated as an organic
acid and gave high values for if a. To evaluate if
any tetracycline hydrochloride was present in the
heptane layer of the extraction system and there-
fore interfering with the ifa titrations from the
study subjects, 2% tetracycline-7-H8 hydrochloride
(approximately 0.01 microcurie/mg) in DMA was
substituted for the regular tetracycline solution.
Two subjects participated in this phase of the
study. Baseline levels of radioactivity in the
heptane layer of the ifa extract were determined
for each of the subjects. The collection of material
from the skin surface for the radioactivity deter-
minations was identical to that used in the usual
ifa technique except that after the aqueous ex-
traction, the radioactivity in the heptane layer
was determined rather than its acid content. This
radioactivity was measured in a liquid scintilla-
tion counter and corrections were made for back-
ground radiation. After these baseline levels were
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TABLE I
Baseline and weekly skin surf ace ffa production rates (peq/6.2 cm2/S hr)for the subjects who applied
tetracycline HC1 in DMA
The mean of each subject's weekly values and the percent change of this mean from their baseline is
presented.
Subject Baseline
Week
Mean % Change
1 2 3 4 5 6 7
1
2
3
4
5
6
7
8
9
.249
.665
.101
.823
.215
.520
.217
.610
.137
—
—
—
—
.127
.410
.169
.530
.131
.104
.376
.049
.560
.179
.372
.157
.420
.089
—
.354
.053
—
—
.345
—
—
—
.086
.362
.069
.510
—
—
—
—
—
.049
.332
—
—
—
—
—
—
—
.020
.324
—
—
—
—
—
—
—
—
.338
—
—
—
—
—
—
—
.065
.348
.057
.535
.153
.376
.163
.475
.110
—74
—48
—44
—35
—29
—28
—25
—22
—20
determined, the 2% tetracycline—7-113 hydrochloride
in DMA was applied daily to the foreheads of the
two subjects. One week later the collections were
repeated and the same procedure was used to
determine the radioactivity in the heptane layer.
An increase in radioactivity above baseline values
would be assumed to be due to tetracycline-7-H°
and an indication that tetracycline hydrochloride
was present in the heptane layer of the extrac-
tion.
The stability of tetracycline hydrochloride in
DMA was studied by a bacteriologic assay. Filter
paper discs saturated with the tetracycline solu-
tion were applied to blood agar plates $treaked
with staphylococcus albus. These plates were then
incubated at 37° for 48 hours. Tetracycline activity
was judged by a zone of bacterial growth inhibi-
tion beyond the margins of the paper disc. The
2% tetracycline hydrochloride-DMA solution was
stored at room temperature for one month and
a sample from the solution was assayed each
week.
RESULTS
Table I outlines the baseline and study data
for skin surfaee ifa production in the nine
subjeets who applied tetracycline hydrochloride
in DMA. Each subject's mean of the weekly
values after starting the tetracyelin.e is also
presented as well as the percent change of this
mean from the baseline value. All nine subjects
showed a fall and the range of decrease was
20 to 74%. Statistical aialysis (t test) of the
differences between each subject's mean study
value aid their baseline value showed that the
difference was highly significant (p < .01 for
the entire group).
Possible correlations between the degree of
ifa change aid baseline values were statisti-
cally evaluated by a rank correlation test. Free
fatty acid values at the end of two and four
weeks of therapy were analyzed for correlation
between baseline values and the degree of re-
duction. At both time intervals the absolute
reductions in ifa were proportional to baseline
values (p < .01 at two weeks and a perfect
correlation at four weeks). There was no cor-
relation between baseline values and per-
centage reduction of ifa after 2 and 4 weeks
of therapy.
Table II outlines the baseliite and study data
for surface total lipid production ii the tetra—
cycline-DMA group. This was determined in
7 of the 9 subjects. These data are presented
in the same form as Table I. No significant
change was observed.
The surface ifa values for the control groups
are presented in Table III. Subjects 10 through
12 were those who applied plain DMA and
subjects 13 through 17 were those who ap-
plied nothing. The control groups showed no
significant change in either ifa or surface total
lipid values.
In the evaluation of possible interference by
tetracycline hydrochloride in the ifa determi-
nation, approximately 5 ml of 2% solution or
100 mg of tetracycline-7-H3-HCI was used by
each subject during the week of daily applica-
tion. All measurements of radioactivity for
this part of the study were made in the same
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TABLE II
Baseline and weekly skin surface total lipid production rates (mg/27.4 cm2 /3 hr)for the szthjects who applied
tetracycline HC1 in DMA
The mean of each subject's weekly values and the percent change of this mean from t.heir baseline is
presented.
Subject Baseline
Week
Mean
4.5
% Change
+10
1 2 3 4 5 6 7
1 4.1 — 4.0 — 5.7 4.1 4.2
2 6.7 — 7.3 L 5.6 L 7.2 6.7 6.7 0
3 2.0 — 2.0 2.2 1.9 — — — 2.0 0
4 3.2 — 3.3 — 3.9 — — — 3.6 +12
5 5.8 5.4 5.8 — — — — — 5.6 —3
6 4.4 4.4 3.2 3.7 — — — — 3.8 —14
9 4.8 4.5 4.5 — — — — 4.5 —6
L is sample lost.
TABLE III
Baseline and weekly Rkin surface ffa prodnclion rates (peq/6.2 cm2/3 hr)for Ihe control .ubjects
(11O—l2 plain DMA; lS—17 no treatment)
Subject Baseline
Week
Mean % Change
1 2 3 4 5 6
,10 .456 .428 L .440 .460 — .— .443 —3
11 .640 .614 .530 .28 .538 — — .553 —14
12 .805 .787 .765 .875 .889 — — .829 +3
13 .330 .340 .316 .360 — — — .338 +2
14 .250 .244 .224 .238 — — — .235 —6
15 .417 .407 .440 .430 .460 .505 — .448 +7
16 .600 .810 .530 .530 .635 — — .626 +4
17 1.750 1.860 1.330 — — 1.595 —9
L is sample lost.
liquid scintillation counter at the same time.
Baseline radioactivity of the ffa extracts before
the tetracvcline-7-H3-HC1 applications was 3
and 8 cpm for the two subjects. After a week
of using the tritium labeled tetracycline HC1,
the activity in the ffa extract was 6 cpm for
both subjects. Such a change is not significant
since the radioactivity of 0.1 ml of the stock
2% tetracycline7-H3-HCl was 10.8 X 10
cpm.
The bacteriologic assay of 2% tetracycline HC1
in DMA showed inhibition of bacterial growth
from samples of the solution which were 1, 2,
3, and 4 weeks old. No gross difference in the
size of the zone of growth inhibition was ob-
served in the samples tested. Samples older
than 4 weeks were not assayed. Plain DMA
showed no inhibition of bacterial growth as
measured by this method.
DISCUSSION
This study demonstrates a statistically sig-
nificant fall in skin surface ffa production by
the topical application of 2% tetracycline
HC1 in DMA. The degree of decrease ranged
from 20% to 74%. The absolute decrease in
ifa after 2 and 4 weeks of therapy was related
to the size of the baseline value; the largest
absolute decreases occurred in those with the
highest baseline ffa values. The tetracycline in
DMA did not produce a. significant change in
skin surface total lipid production. No sig-
nificant change in either ffa or surface total
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lipid was shown in controls who applied plain
DMA or in controls who applied nothing.
Interference by tetracycline IICI in the ifa
quantitation by interference in the ifa titration
was ruled out by the demonstration that no
tetracycline HC1 was present in the titration
system. The antibacterial stability of tetracy-
clhm HC1 in DMA for periods up to four weeks
was shown by an assay of bacteriostatic ac-
tivity.
There were several reasons why DMA was
chosen as the solvent for the tetracycline.
Tetracycline HC1 is readily soluble in DMA
in the concentrations used in this study. This
solvent increases the percutaneous absorption
and stratum corneum retention of certain
pharmacologic compounds (3). It is known
that DMA enhances the deposition of hexa-
chlorophene in the horny layer and increases
its bacteriostatic effectiveness as compared to
hexa chlorophene in conventional detergent
vehicles (4). The effect of DMA on percutane-
ous absorption and stratum corneum reten-
tion of tetracycline is not known.
The results of this study are similar to those
obtained with systemic tetracycline in a dose
of 250 mg four times a day (1). Neither study
found a significant alteration in skin surface
total lipid production. The baseline mean
casual ffa value for all subjects receiving sys-
temic tetracycline was 0.85 teq/sample; dur-
ing the first three weeks of therapy it was
0.56 eq/sample; during the second three
weeks of therapy it was 0.44 eciJsample. This
is a 34% reduction during the first three weeks
and a 48% reduction during the second three
weeks. When each subject's mean 3-hour ifa
value during the first 2 to 3 weeks of topical
tetracycline therapy (depending on the dura
tion of therapy) is compared to their baseline
value, the percent reductiolls range from 20%
to 58% with a mean for the nine subjects of
34%. Four subjects continued to apply topical
tetracycline for 1 to 3 weeks of the second
three-week interval. Their reductions in ifa
during this time ranged from 32% to 79% with
a mean of 50%.
SUMMARY
A reduction in skin surface free fatty acids
was produced by the topical application of
tetracycline in N, N-dimethylacetamide.
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